Baseline characteristics of 43 145 men with a first myocardial infarction during 2007 to 2013 in Sweden in relation to treatment for erectile dysfunction
| All men | No treatment for erectile dysfunction | Treatment for erectile dysfunction | |
| Men, number | 43 145 | 40 077 | 3068 |
| Age, years, mean (SD) | 64 (10) | 64 (10) | 61 (9.0) |
| Heart failure, n (%) | 873 (2.0) | 854 (2.1) | 19 (0.6) |
| Diabetes, n (%) | 5392 (13) | 5083 (13) | 309 (10) |
| COPD | 677 (1.6) | 652 (1.6) | 25 (0.8) |
| Stroke, n (%) | 2505 (5.8) | 2407 (6.0) | 98 (3.2) |
| PAD, n (%) | 238 (0.6) | 230 (0.6) | 8 (0.3) |
| Active cancer, n (%) | 545 (1.3) | 522 (1.3) | 23 (0.8) |
| Betablockers, n (%) | 9285 (22) | 8790 (22) | 495 (16) |
| Statins, n (%) | 7240 (17) | 6827 (17) | 413 (13) |
| ACE/ARB, n (%) | 11 286 (26) | 10 585 (26) | 701 (23) |
| Nitrates, n (%) | 2398 (5.6) | 2291 (5.7) | 107 (3.5) |
| Thiazides, n (%) | 7804 (18) | 7397 (18) | 407 (13) |
| Platelet inhibitors, n (%) | 7938 (18) | 7553 (19) | 385 (13) |
| Opioids, n (%) | 3268 (7.6) | 3035 (7.6) | 233 (7.6) |
| SSRI, n (%) | 1894 (4.4) | 1800 (4.5) | 94 (3.1) |
| Neuroleptics, n (%) | 639 (1.5) | 618 (1.5) | 21 (0.7) |
| CCB, n (%) | 6986 (16) | 6610 (16) | 376 (12) |
This table includes only patients who survived to 30 days after the index date.
ARB, angiotensinogen-receptor blocker; CCB, calcium channel blocker; COPD, chronic obstructive pulmonary disease; PAD, peripheral artery disease; SSRI, selective serotonin reuptake inhibitor.